Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis

NCT06589219 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Fibroses, Idiopathic

Interventions

DRUG: CMR316
DRUG: Placebo

Sponsor

Calibr, a division of Scripps Research